Pharma Company Targeting Aging Sees Stock Soar, BTIG Initiates Buy Rating

A biopharmaceutical company focused on anti-aging treatments has experienced a significant surge in its stock price this year. Investment firm BTIG has initiated coverage with a buy rating, predicting further growth.

13 May, 15:30 — 13 May, 15:30

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual42d ago

This pharma name targeting aging has soared this year. BTIG thinks it can double from here

The investment firm initiated coverage of the biopharmaceutical name with a buy rating.

Read full article →

PERSPECTA

PERSPECTA

Pharma Company Targeting Aging Sees Stock Soar, BTIG Initiates Buy Rating

Sources

This pharma name targeting aging has soared this year. BTIG thinks it can double from here

Related Stories

Marilyn Monroe's 50th Death Anniversary

Slovak Ice Swimmer Soňa Rebrová Battles Challenges

Philippine Army Claims NPA Fighters in Northern Mindanao Reduced to 16

Bangsamoro Chief Welcomes Peace Rally by MILF Supporters

PERSPECTA